Corrigendum for: Ovariectomy alters gene expression of the hippocampal formation in middle-aged rats (Endocrinology (2017) 158:1 (69-83) DOI: 10.1210/en.2016-1516);Ovariectomy alters gene expression of the hippocampal formation in middle-aged rats

Endocrinology (United States)

Volumn 158, Issue 1, 2017, Pages 69-83

  Sárvári, Miklós ^a   Kalló, Imre ^a,b   Hrabovszky, Erik ^a   Solymosi, Norbert ^c   Liposits, Zsolt ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

^c UNIVERSITY OF VETERINARY MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; BETA SYNUCLEIN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; ENDOCANNABINOID; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR 1; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR IONOTROPHIC AMPA 4; GLUTAMATE RECEPTOR METABOTROPIC 1; GLUTAMINASE; GONADORELIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KLOTHO PROTEIN; MIDKINE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN 3; NUCLEAR RECEPTOR NR4A3; ORTHODENTICLE HOMEOBOX 2; PREALBUMIN; RAS LIKE ESTROGEN REGULATED GROWTH NHIBITOR; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SOMATOMEDIN B; TRANSCRIPTION FACTOR OTX2; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 2; VESICULAR MONOAMINE TRANSPORTER 2; TRANSCRIPTOME;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; GONADECTOMY; HIPPOCAMPUS; IMMUNOMODULATION; LONG TERM CARE; MICROARRAY ANALYSIS; MIDDLE AGED; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; OVARIECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; MENOPAUSE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; WISTAR RAT;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; HIPPOCAMPUS; MENOPAUSE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIECTOMY; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 85008465319     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2017-00514     Document Type: Erratum

References (112)

1. McCarthy MM, Schwarz JM, Wright CL, Dean SL. Mechanisms mediating oestradiol modulation of the developing brain. J Neuroendocrinol. 2008;20(6):777-783.
2. McEwen BS. Steroid hormones and the brain: cellular mechanisms underlying neural and behavioral plasticity. Psychoneuroendocrinology. 1980;5(1):1-11.
3. McEwen BS. Steroid hormones and the chemistry of behavior. Adv Behav Biol. 1972;4:41-59.
4. Knobil E. The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res. 1980;36:53-88.
5. Brann DW, Mahesh VB. The aging reproductive neuroendocrine axis. Steroids. 2005;70(4):273-283.
6. Nelson JF, Bergman MD, Karelus K, Felicio LS. Aging of the hypothalamo-pituitary-ovarian axis: hormonal influences and cellular mechanisms. J Steroid Biochem. 1987;27(4-6):699-705.
7. Boulware MI, Kent BA, Frick KM. The impact of age-related ovarian hormone loss on cognitive and neural function. Curr Top Behav Neurosci. 2012;10:165-184.
8. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257-275.
9. Langer RD, Manson JE, Allison MA. Have we come full circle - or moved forward? The Women's Health Initiative 10 years on. Climacteric. 2012;15(3):206-212.
10. Gompel A, Santen RJ. Hormone therapy and breast cancer risk 10 years after the WHI. Climacteric. 2012;15(3):241-249.
11. European Medicines Agency. Guidelines on clinical investigation of medicinal products for hormone replacement therapy of oestrogen deficiency symptoms in postmenopausal women. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003348.pdf. Accessed 2005.
12. US Food and Drug Administration. Estrogen and estrogen with progestin therapies for postmenopausal women. Available at: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm135318.htm. Accessed 2004.
13. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH, Endocrine S; Endocrine Society. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010;95(7, Suppl 1):S1-S66.
14. Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA, De Jager PL. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014;82(3):222-229.
15. Bean LA, Kumar A, Rani A, Guidi M, Rosario AM, Cruz PE, Golde TE, Foster TC. Re-opening the critical window for estrogen therapy. J Neurosci. 2015;35(49):16077-16093.
16. Voytko ML, Murray R, Higgs CJ. Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone. J Neurosci. 2009;29(33):10362-10370.
17. Tinkler GP, Voytko ML. Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(3):423-431.
18. Sá rvá ri M, KallóI, Hrabovszky E, Solymosi N, Tóth K, LikóI, Molnár B, Tihanyi K, Liposits Z. Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats. Endocrinology. 2010;151(8):3847-3862.
19. Daniel JM, Hulst JL, Berbling JL. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology. 2006;147(1):607-614.
20. Bimonte-Nelson HA, Francis KR, Umphlet CD, Granholm AC. Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats. Eur J Neurosci. 2006;24(1):229-242.
21. Foster TC. Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus. 2012;22(4):656-669.
22. Aenlle KK, Kumar A, Cui L, Jackson TC, Foster TC. Estrogen effects on cognition and hippocampal transcription in middleaged mice. Neurobiol Aging. 2009;30(6):932-945.
23. Fernandez SM, Frick KM. Chronic oral estrogen affects memory and neurochemistry in middle-aged female mice. Behav Neurosci. 2004;118(6):1340-1351.
24. Sá rvá ri M, KallóI, Hrabovszky E, Solymosi N, Liposits Z. Ovariectomy and subsequent treatment with estrogen receptor agonists tune the innate immune system of the hippocampus in middle-aged female rats. PLoS One. 2014;9(2):e88540.
25. Sárvári M, Kalló I, Hrabovszky E, Solymosi N, Rodolosse A, Liposits Z. Long-term estrogen receptor beta agonist treatment modifies the hippocampal transcriptome in middle-aged ovariectomized rats. Front Cell Neurosci. 2016;10:149.
26. Sárvári M, Kalló I, Hrabovszky E, Solymosi N, Rodolosse A, Vastagh C, Auer H, Liposits Z. Hippocampal gene expression is highly responsive to estradiol replacement in middle-aged female rats. Endocrinology. 2015;156(7):2632-2645.
27. Kumar A, Bean LA, Rani A, Jackson T, Foster TC. Contribution of estrogen receptor subtypes, ERa, ERb, and GPER1 in rapid estradiol-mediated enhancement of hippocampal synaptic transmission in mice. Hippocampus. 2015;25(12):1556-1566.
28. Bean LA, Ianov L, Foster TC. Estrogen receptors, the hippocampus, and memory. Neuroscientist. 2014;20(5):534-545.
29. Han X, Aenlle KK, Bean LA, Rani A, Semple-Rowland SL, Kumar A, Foster TC. Role of estrogen receptor α and β in preserving hippocampal function during aging. J Neurosci. 2013;33(6):2671-2683.
30. Tanapat P, Hastings NB, Gould E. Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a doseand time-dependent manner. J Comp Neurol. 2005;481(3):252-265.
31. Tanapat P, Hastings NB, Reeves AJ, Gould E. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J Neurosci. 1999;19(14):5792-5801.
32. Etgen AM, Jover-Mengual T, Zukin RS. Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications. Front Neuroendocrinol. 2011;32(3):336-352.
33. Lebesgue D, Traub M, De Butte-Smith M, Chen C, Zukin RS, Kelly MJ, Etgen AM. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One. 2010;5(1):e8642.
34. Arevalo MA, Azcoitia I, Garcia-Segura LM. The neuroprotective actions of oestradiol and oestrogen receptors. Nat Rev Neurosci. 2015;16(1):17-29.
35. Sárvári M, Hrabovszky E, KallóI, Galamb O, Solymosi N, LikóI, Molnár B, Tihanyi K, Szombathelyi Z, Liposits Z. Gene expression profiling identifies key estradiol targets in the frontal cortex of the rat. Endocrinology. 2010;151(3):1161-1176.
36. Lu KH, Hopper BR, Vargo TM, Yen SS. Chronological changes in sex steroid, gonadotropin and prolactin secretions in aging female rats displaying different reproductive states. Biol Reprod. 1979;21(1):193-203.
37. Wheeler DW, White CM, Rees CL, Komendantov AO, Hamilton DJ, Ascoli GA. Hippocampome.org: a knowledge base of neuron types in the rodent hippocampus. eLife. 2015;4:4.
38. Freund TF, Buzsáki G. Interneurons of the hippocampus. Hippocampus. 1996;6(4):347-470.
39. Buckmaster PS, Soltesz I. Neurobiology of hippocampal interneurons: a workshop review. Hippocampus. 1996;6(3):330-339.
40. Klausberger T, Somogyi P. Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science. 2008;321(5885):53-57.
41. Roux L, Stark E, Sjulson L, Buzsáki G. In vivo optogenetic identification and manipulation of GABAergic interneuron subtypes. Curr Opin Neurobiol. 2014;26:88-95.
42. Fuzik J, Zeisel A, Má téZ, Calvigioni D, Yanagawa Y, SzabóG, Linnarsson S, Harkany T. Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes. Nat Biotechnol. 2016;34(2):175-183.
43. Chamberland S, Topolnik L. Inhibitory control of hippocampal inhibitory neurons. Front Neurosci. 2012;6:165.
44. Bezaire MJ, Soltesz I. Quantitative assessment of CA1 local circuits: knowledge base for interneuron-pyramidal cell connectivity. Hippocampus. 2013;23(9):751-785.
45. Krook-Magnuson E, Varga C, Lee SH, Soltesz I. New dimensions of interneuronal specialization unmasked by principal cell heterogeneity. Trends Neurosci. 2012;35(3):175-184.
46. Dauge V, Bohme GA, Crawley JN, Durieux C, Stutzmann JM, Feger J, Blanchard JC, Roques BP. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264. Synapse. 1990;6(1):73-80.
47. Bö hme GA, Stutzmann JM, Blanchard JC. Excitatory effects of cholecystokinin in rat hippocampus: pharmacological response compatible with "central"- or B-type CCK receptors. Brain Res. 1988;451(1-2):309-318.
48. Cunha-Reis D, Sebastião AM, Wirkner K, Illes P, Ribeiro JA. VIP enhances both pre- and postsynaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells. Br J Pharmacol. 2004;143(6):733-744.
49. Li S, Geiger JD, Lei S. Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels. J Neurophysiol. 2008;99(5):2134-2143.
50. Lee HK, Dunwiddie T, Hoffer B. Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. II. Effects on interneuron excitability. Brain Res. 1980;184(2):331-342.
51. Dunwiddie T, Mueller A, Palmer M, Stewart J, Hoffer B. Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. I. Effects on pyramidal cell activity. Brain Res. 1980;184(2):311-330.
52. Cohen GA, Doze VA, Madison DV. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron. 1992;9(2):325-335.
53. Taylor RD, Madsen MG, Krause M, Sampedro-Castañeda M, Stocker M, Pedarzani P. Pituitary adenylate cyclase-activating polypeptide (PACAP) inhibits the slow afterhyperpolarizing current sIAHP in CA1 pyramidal neurons by activating multiple signaling pathways. Hippocampus. 2014;24(1):32-43.
54. Ago Y, Yoneyama M, Ishihama T, Kataoka S, Kawada K, Tanaka T, Ogita K, Shintani N, Hashimoto H, Baba A, Takuma K, Matsuda T. Role of endogenous pituitary adenylate cyclaseactivating polypeptide in adult hippocampal neurogenesis. Neuroscience. 2011;172:554-561.
55. Mercer A, Rö nnholm H, Holmberg J, Lundh H, Heidrich J, Zachrisson O, Ossoinak A, Frisén J, Patrone C. PACAP promotes neural stem cell proliferation in adult mouse brain. J Neurosci Res. 2004;76(2):205-215.
56. Riek-Burchardt M, Kolodziej A, Henrich-Noack P, Reymann KG, Höllt V, Stumm R. Differential regulation of CXCL12 and PACAP mRNA expression after focal and global ischemia. Neuropharmacology. 2010;58(1):199-207.
57. Uchida D, Arimura A, Somogyvári-Vigh A, Shioda S, Banks WA. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res. 1996;736(1-2):280-286.
58. Rebaudo R, Melani R, Balestrino M, Izvarina N. Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices. Brain Res. 2001;922(1):112-117.
59. Bharne AP, Borkar CD, Bodakuntla S, Lahiri M, Subhedar NK, Kokare DM. Pro-cognitive action of CART is mediated via ERK in the hippocampus. Hippocampus. 2016;26(10):1313-1327.
60. Abraham CR, Mullen PC, Tucker-Zhou T, Chen CD, Zeldich E. Klotho is a neuroprotective and cognition-enhancing protein. Vitam Horm. 2016;101:215-238.
61. Yang SN, Lu F, Wu JN, Liu DD, Hsieh WY. Activation of gonadotropin-releasing hormone receptors induces a long-term enhancement of excitatory postsynaptic currents mediated by ionotropic glutamate receptors in the rat hippocampus. Neurosci Lett. 1999;260(1):33-36.
62. Lu F, Yang JM, Wu JN, Chen YC, Kao YH, Tung CS, Yang SN. Activation of gonadotropin-releasing hormone receptors produces neuronal excitation in the rat hippocampus. Chin J Physiol. 1999;42(2):67-71.
63. Abel TW, Rance NE. Stereologic study of the hypothalamic infundibular nucleus in young and older women. J Comp Neurol. 2000;424(4):679-688.
64. Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, Yin Y, Li B, Liu G, Cai D. Hypothalamic programming of systemic ageing involving IKK-b, NF-kB and GnRH. Nature. 2013;497(7448):211-216.
65. Vizi ES, Kiss JP. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 1998;8(6):566-607.
66. Lujan R, Nusser Z, Roberts JD, Shigemoto R, Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci. 1996;8(7):1488-1500.
67. Baude A, Nusser Z, Roberts JD, Mulvihill E, McIlhinney RA, Somogyi P. The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron. 1993;11(4):771-787.
68. Baude A, Nusser Z, Molnár E, McIlhinney RA, Somogyi P. Highresolution immunogold localization of AMPA type glutamate receptor subunits at synaptic and non-synaptic sites in rat hippocampus. Neuroscience. 1995;69(4):1031-1055.
69. Nusser Z, Lujan R, Laube G, Roberts JD, Molnar E, Somogyi P. Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron. 1998;21(3):545-559.
70. He H, Mahnke AH, Doyle S, Fan N, Wang CC, Hall BJ, Tang YP, Inglis FM, Chen C, Erickson JD. Neurodevelopmental role for VGLUT2 in pyramidal neuron plasticity, dendritic refinement, and in spatial learning. J Neurosci. 2012;32(45):15886-15901.
71. Alves SH, Pinheiro G, Motta V, Landeira-Fernandez J, Cruz AP. Anxiogenic effects in the rat elevated plus-maze of 5-HT (2C) agonists into ventral but not dorsal hippocampus. Behav Pharmacol. 2004;15(1):37-43.
72. Nair SG, Gudelsky GA. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat. Synapse. 2004;53(4):202-207.
73. Kenney JW, Gould TJ. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol. 2008;38(1):101-121.
74. Lobron C, Wevers A, Dämgen K, Jeske A, Rontal D, Birtsch C, Heinemann S, Reinhardt S, Maelicke A, Schrö der H. Cellular distribution in the rat telencephalon of mRNAs encoding for the alpha 3 and alpha 4 subunits of the nicotinic acetylcholine receptor. Brain Res Mol Brain Res. 1995;30(1):70-76.
75. Stelly CE, Cronin J, Daniel JM, Schrader LA. Long-term oestradiol treatment enhances hippocampal synaptic plasticity that is dependent on muscarinic acetylcholine receptors in ovariectomised female rats. J Neuroendocrinol. 2012;24(6):887-896.
76. Davis DM, Jacobson TK, Aliakbari S, Mizumori SJ. Differential effects of estrogen on hippocampal- and striatal-dependent learning. Neurobiol Learn Mem. 2005;84(2):132-137.
77. Daniel JM, Witty CF, Rodgers SP. Long-term consequences of estrogens administered in midlife on female cognitive aging. Horm Behav. 2015;74:77-85.
78. Rodgers SP, Bohacek J, Daniel JM. Transient estradiol exposure during middle age in ovariectomized rats exerts lasting effects on cognitive function and the hippocampus. Endocrinology. 2010;151(3):1194-1203.
79. Medhurst AD, Atkins AR, Beresford IJ, Brackenborough K, Briggs MA, Calver AR, Cilia J, Cluderay JE, Crook B, Davis JB, Davis RK, Davis RP, Dawson LA, Foley AG, Gartlon J, Gonzalez MI, Heslop T, Hirst WD, Jennings C, Jones DN, Lacroix LP, Martyn A, Ociepka S, Ray A, Regan CM, Roberts JC, Schogger J, Southam E, Stean TO, Trail BK, Upton N, Wadsworth G, Wald JA, White T, Witherington J, Woolley ML, Worby A, Wilson DM. GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther. 2007;321(3):1032-1045.
80. Fukui M, Rodriguiz RM, Zhou J, Jiang SX, Phillips LE, Caron MG, Wetsel WC. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci. 2007;27(39):10520-10529.
81. Carrer HF, Araque A, Buño W. Estradiol regulates the slow Ca2+ activated K+ current in hippocampal pyramidal neurons. J Neurosci. 2003;23(15):6338-6344.
82. Jamali K, Naylor BR, Kelly MJ, Rønnekleiv OK. Effect of 17betaestradiol on mRNA expression of large-conductance, voltagedependent, and calcium-activated potassium channel alpha and beta subunits in guinea pig. Endocrine. 2003;20(3):227-237.
83. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, Latorre R. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science. 1999;285(5435):1929-1931.
84. Kelly MJ, Qiu J, Rønnekleiv OK. Estrogen modulation of Gproteincoupled receptor activation of potassium channels in the central nervous system. Ann N Y Acad Sci. 2003;1007:6-16.
85. Humphries ES, Dart C. Neuronal and cardiovascular potassium channels as therapeutic drug targets: promise and pitfalls. J Biomol Screen. 2015;20(9):1055-1073.
86. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14(23):2919-2937.
87. Gómez-Palacio-Schjetnan A, Escobar ML. Neurotrophins and synaptic plasticity. Curr Top Behav Neurosci. 2013;15:117-136.
88. Ramos-Languren LE, Escobar ML. Plasticity and metaplasticity of adult rat hippocampal mossy fibers induced by neurotrophin-3. Eur J Neurosci. 2013;37(8):1248-1259.
89. Gage FH, Buzsáki G, Armstrong DM. NGF-dependent sprouting and regeneration in the hippocampus. Prog Brain Res. 1990;83:357-370.
90. Hennigan A, O'Callaghan RM, Kelly AM. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem Soc Trans. 2007;35(2):424-427.
91. Bracko O, Singer T, Aigner S, Knobloch M, Winner B, Ray J, Clemenson GD, Jr, Suh H, Couillard-Despres S, Aigner L, Gage FH, Jessberger S. Gene expression profiling of neural stem cells and their neuronal progeny reveals IGF2 as a regulator of adult hippocampal neurogenesis. J Neurosci. 2012;32(10):3376-3387.
92. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, Blitzer RD, Alberini CM. A critical role for IGF-II in memory consolidation and enhancement. Nature. 2011;469(7331):491-497.
93. Sasaki K, Oomura Y, Suzuki K, Hanai K, Yagi H. Acidic fibroblast growth factor prevents death of hippocampal CA1 pyramidal cells following ischemia. Neurochem Int. 1992;21(3):397-402.
94. Sasaki K, Oomura Y, Figurov A, Yagi H. Acidic fibroblast growth factor facilitates generation of long-term potentiation in rat hippocampal slices. Brain Res Bull. 1994;33(5):505-511.
95. Kim YB, Ryu JK, Lee HJ, Lim IJ, Park D, Lee MC, Kim SU. Midkine, heparin-binding growth factor, blocks kainic acidinduced seizure and neuronal cell death in mouse hippocampus. BMC Neurosci. 2010;11:42.
96. Duarte-Guterman P, Yagi S, Chow C, Galea LA. Hippocampal learning, memory, and neurogenesis: Effects of sex and estrogens across the lifespan in adults. Horm Behav. 2015;74:37-52.
97. Lisowski P, Juszczak GR, Goscik J, Stankiewicz AM, Wieczorek M, Zwierzchowski L, Swiergiel AH. Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice. BMC Neurosci. 2013;14:144.
98. Jin KL, Mao XO, Nagayama T, Goldsmith PC, Greenberg DA. Induction of vascular endothelial growth factor and hypoxiainducible factor-1alpha by global ischemia in rat brain. Neuroscience. 2000;99(3):577-585.
99. McCaffery P, Zhang J, Crandall JE. Retinoic acid signaling and function in the adult hippocampus. J Neurobiol. 2006;66(7):780-791.
100. Remaud S, Gothié JD, Morvan-Dubois G, Demeneix BA. Thyroid hormone signaling and adult neurogenesis in mammals. Front Endocrinol (Lausanne). 2014;5:62.
101. Xu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X. NLRP3 inflammasome activation mediates estrogen deficiency-induced depressionand anxiety-like behavior and hippocampal inflammation in mice. Brain Behav Immun. 2016;56:175-186.
102. Chan PH, Kawase M, Murakami K, Chen SF, Li Y, Calagui B, Reola L, Carlson E, Epstein CJ. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci. 1998;18(20):8292-8299.
103. Nilsen J, Diaz Brinton R. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci USA. 2003;100(5):2842-2847.
104. Sales S, Ureshino RP, Pereira RT, Luna MS, Pires de Oliveira M, Yamanouye N, Godinho RO, Smaili SS, Porto CS, Abdalla FM. Effects of 17beta-estradiol replacement on the apoptotic effects caused by ovariectomy in the rat hippocampus. Life Sci. 2010;86(21-22):832-838.
105. Sharma K, Mehra RD. Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax. Brain Res. 2008;1204:1-15.
106. Sugawara T, Noshita N, Lewén A, Gasche Y, Ferrand-Drake M, Fujimura M, Morita-Fujimura Y, Chan PH. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci. 2002;22(1):209-217.
107. Zhao L, Wu TW, Brinton RD. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 2004;1010(1-2):22-34.
108. Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E. Beta-synuclein regulates Akt activity in neuronal cells: a possible mechanism for neuroprotection in Parkinson's disease. J Biol Chem. 2004;279(22):23622-23629.
109. Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, Marr R, Masliah E. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene Ther. 2004;11(23):1713-1723.
110. Au A, Feher A, McPhee L, Jessa A, Oh S, Einstein G. Estrogens, inflammation and cognition. Front Neuroendocrinol. 2016;40:87-100.
111. Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, Santoro N, Simoncini T. Menopause. Nat Rev Dis Primers. 2015;1:15004.
112. Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011